GENE ONLINE|News &
Opinion
Blog

Regulatory
COVID-19 Antibody Cocktail
COVID-19: After Lilly, Regeneron Bags EUA for its Antibody Therapy
2020-11-24
Trials & Approvals Blood Clotting
uniQure’s Gene Therapy Impresses in Pivotal Trial Raising Hopes of a Hemophilia B Cure
2020-11-22
COVID-19 Stem Cell Therapy
Novartis Secures Exclusive Rights of Mesoblast’s Cell Therapy for COVID-19 Related ARDS
2020-11-21
Trials & Approvals Amyotrophic Lateral Sclerosis
Brainstorm’s Stem Cell Therapy Flunks Phase 3 ALS Trial
2020-11-20
Trials & Approvals Non-alcoholic Steatohepatitis
Gilead and Novo Nordisk Present Proof-of-Concept Data for the First Possible NASH Treatment
2020-11-17
Trials & Approvals Influenza
Roche’s Influenza Drug Bags Recommendation for EU Approval
2020-11-15
Trials & Approvals Renal Cell Carcinoma
Merck, Eisai’s Combo Therapy Registers Superiority against Pfizer’s Drug in Kidney Cancer Trial
2020-11-15
Technology PTSD
FDA Allows Marketing of New Device to Reduce Nightmare-Related Sleep Disturbances in Adults
2020-11-13
Trials & Approvals Atopic Dermatitis
Pfizer’s JAK1 Inhibitor Impresses in Phase 3 Atopic Dermatitis Trial
2020-11-12
Trials & Approvals Asthma
Amgen, AstraZeneca’s Tezepelumab Impresses in Phase 3 Asthma Trial
2020-11-11
Trials & Approvals NGS
Foundation Medicine’s Liquid Biopsy Test Bags FDA Approval for Eighth Indication as Companion Diagnostic
2020-11-10
Trials & Approvals Atopic Dermatitis
Pfizer Announces Positive Top-Line Results for JAK Inhibitor in Ankylosing Spondylitis Trial
2020-11-08
Trials & Approvals Alzheimer's Disease
Biogen’s Alzheimer’s Drug Turned Down by Independent Panel
2020-11-07
Trials & Approvals IL-17A
Novartis’ IL-17 Inhibitor Shines in Late-Stage Psoriatic Arthritis Trial
2020-11-06
Trials & Approvals NSCLC
Jounce Discontinues Phase 2 NSCLC Trial After its Combo Therapy with Ipilimubab Folds
2020-11-06
1 … 39 40 41 42 43 … 53
LATEST
Profluent Achieves Human Genome Editing Milestone Using OpenCRISPR-1: The First AI-Generated, Open-Source Gene Editor
2024-05-08
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top